Table 8 Final post-operative histopathological diagnosis
From: MR diffusion versus MR perfusion in patients with ovarian tumors; how far could we get?
Type | Benign | Borderline | Malignant | Total |
|---|---|---|---|---|
Epithelial tumors | 24 (51.1%) | |||
Serous | 3 (6.3%) | 3 (6.3%). | 6 (12.7%). | |
Mucinous | 3 (6.3%) | 1(2.1%) | 3 (6.3%). | |
Brenner’s | – | – | 2 (4.2%). | |
Clear cell carcinoma | – | – | 1 (2.1%). | |
Undifferentiated carcinoma | – | – | 1 (2.1%). | |
Endometroid carcinoma | – | – | 1 (2.1%). | |
Sex cord-stromal tumors | 8 (17%) | |||
Fibrothecoma/fibroma | 4 (8.5%) | – | – | |
Benign sclerosing tumor | 1 (2.1%) | – | – | |
Granulosa cell tumor | – | – | 3 (6.3%). | |
Germ cell tumors | 15 (31.9%) | |||
Mature cystic teratoma | 4 (8.5%) | – | – | |
Struma ovarii | 3 (6.3%) | – | – | |
Immature teratoma | – | – | 4 (8.5%) | |
Dysgerminoma | – | – | 4 (8.5%). |